Saphetor equips laboratories, hospitals, and life sciences organizations with the clarity, confidence, and scale needed to act on genomic data.
VarSome is home to a leading genomics interpretation community - a global community of users who contribute knowledge, share variant data, and access curated resources every day. This collaboration helps ensure scientific insights translate into better outcomes for patients, families, and research teams.
Evidence at scale: Driven by 140+ curated and regularly updated data sources.
Guideline-driven Interpretation: Classification aligned with ACMG/AMP guidelines and other international standards.
Trusted Worldwide: Adopted by hospitals, laboratories, and life sciences organizations across the globe.
Regulatory compliance: CE-IVDR Class C certified, helping laboratories and hospitals meet clinical accreditation requirements.
Saphetor collaborates with leading laboratories, hospitals, and life sciences organizations worldwide. These partnerships ensure our platform remains closely aligned with real clinical and research needs, while expanding the reach and impact of genomic interpretation.
A member of the
Gencell Pharma, a leading genomics company in Latin America, provides advanced sequencing and molecular diagnostics. In this series of clips, their team share how VarSome supports accuracy in variant interpretation, increases speed in data processing, and strengthens collaboration between organizations. Our partnership has helped Gencell expand capacity, improve quality, and deliver reliable results to patients and clinicians across the region.
“Partnering with Saphetor has been transformative. It gave us a competitive advantage.”
Fabio Andrés Zapata - CEO, Gencell Pharma
"We look forward to leveraging Saphetor's innovative approach to bring together the global genomics community to build awareness in our rare disease program."
PTC Therapeutics
“Saphetor’s support has been amazing regarding problem resolution, error mitigation, operability, and transfer speed.”
Joseph Monroy - IT Coordinator, Gencell Pharma
"We had another person agree to participate in our clinical trial. That's a great record of success."
SAOL Therapeutics
